Methyclothiazide and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Methyclothiazide and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methyclothiazide
Brand name: Aquatensen, Enduron
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methyclothiazide-Moxifloxacin
- Methyclothiazide-Moxifloxacin (Systemic)
- Methyclothiazide-Moxifloxacin Hydrochloride
- Methyclothiazide-Moxifloxacin Injection
- Methyclothiazide-Moxifloxacin Intravenous
- Methyclothiazide-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Methyl Aminolevulinate
- Moxetumomab pasudotox-tdfk Intravenous-Methyl aminolevulinate topical
- Moxetumomab pasudotox-tdfk Intravenous-Methyl aminolevulinate Topical application
- Moxetumomab pasudotox-tdfk Intravenous-Methyl B-12 vitamin B12
- Moxetumomab pasudotox-tdfk Intravenous-Methyl Salicylate and Menthol Cream and Ointment
- Moxetumomab pasudotox-tdfk Intravenous-Methyl Salicylate and Menthol Lotion